Strategic Acquisition The recent acquisition of Elevated Softgels by CV Sciences positions the company within a larger, well-established industry player, potentially opening opportunities for collaboration, expanded product lines, and integrated supply chain solutions.

Growing Market Presence Operating within the rapidly expanding hemp and CBD sector with revenue between one and ten million dollars, Elevated Softgels presents an opportunity to target emerging brands and companies seeking reliable contract manufacturing services.

Product Customization Focus Specializing in softgels, vapes, gummies, and tinctures for the hemp/CBD market, elevated softgels offers tailored formulations, making it an ideal partner for startups and established brands aiming to differentiate through innovative product offerings.

Boutique Manufacturing Scale With a relatively small team of 11-50 employees, Elevated Softgels is positioned as a flexible, responsive partner that can support personalized, small-batch production—appealing to emerging companies and niche brands.

Industry Alignment and Trends Given its focus on wellness products and recent corporate integration, there is an opportunity to provide complementary services such as premium ingredient sourcing, packaging solutions, or expansion into new product categories aligned with current wellness trends.